Saccharomyces cerevisiae as an eukaryotic cell model to assess cytotoxicity and genotoxicity of three anticancer anthraquinones

被引:41
作者
Buschini, A [1 ]
Poli, P [1 ]
Rossi, C [1 ]
机构
[1] Univ Parma, Ist Genet, I-43100 Parma, Italy
关键词
D O I
10.1093/mutage/18.1.25
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The toxicity of most drugs is associated with their enzymatic conversion to toxic metabolites. Bioactivation reactions occur in a range of cellular organs and organelles, including mitochondria. We have investigated different effects (i.e. growth inhibition, mortality and genotoxicity) of doxorubicin, epirubicin and mitoxantrone on the D7 strain of Saccharomyces cerevisiae and on its petite (rhodegrees) respiratory-deficient mutant at various cellular concentrations of cytochrome P450 and glutathione (GSH). The data confirmed the importance of oxygen production for doxorubicin toxicity. The complete absence, or a very low level, of cytochrome oxidase subunit IV conferred some resistance to doxorubicin. Low GSH levels decreased resistance to doxorubicin in both strains, suggesting that thiol depletion could potentiate membrane lipid peroxidation. Doxorubicin induction of petite colonies suggests that the drug is able to select rather than induce respiratory-deficient mutants. Epirubicin induced levels of cytotoxicity similar to those of doxorubicin. The effects did not appear to be significantly dependent on mitochondrial function or GSH levels, whereas cells were strongly protected by cytochrome P450. GSH did not induce an evident alteration. Neither were genotoxic effects induced. Mitoxantrone had reduced levels of both growth inhibition and cytotoxicity in comparison to anthracyclines and induced convertants, revertants and aberrants. All the effects considered were amplified at high cytochrome P450 cellular concentrations, although the drug was also shown to act without previous metabolism via cytochrome P450. Anthracenedione effectiveness was increased by metabolism via cytochrome P450 and partially reduced by GSH. However, further mechanisms were suggested, which might implicate mitochondrial function and/or production of electrophilic cytotoxic and/or genotoxic intermediates by means of GSH conjugation. The biological effectiveness of doxorubicin, epirubicin and mitoxantrone on S.cerevisiae was shown to be strictly dependent on cell-specific physiological/biochemical conditions, such as a functional respiratory chain and levels of cytochrome P450 and GSH.
引用
收藏
页码:25 / 36
页数:12
相关论文
共 79 条
[1]  
ALBIN N, 1993, CANCER RES, V53, P3541
[2]   Anthracycline antibiotic blockade of SV40 T antigen helicase action [J].
Bachur, NR ;
Lun, L ;
Sun, PM ;
Trubey, CM ;
Elliott, EE ;
Egorin, MJ ;
Malkas, L ;
Hickey, R .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (07) :1025-1034
[3]  
BACHUR NR, 1978, CANCER RES, V38, P1745
[4]   Novel anthraquinone derivatives with redox-active functional groups capable of producing free radicals by metabolism: are free radicals essential for cytotoxicity? [J].
Barasch, D ;
Zipori, O ;
Ringel, I ;
Ginsburg, I ;
Samuni, A ;
Katzhendler, J .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1999, 34 (7-8) :597-615
[5]   ROLE OF GLUTATHIONE AND ITS ASSOCIATED ENZYMES IN MULTIDRUG-RESISTANT HUMAN MYELOMA CELLS [J].
BELLAMY, WT ;
DALTON, WS ;
MELTZER, P ;
DORR, RT .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (05) :787-793
[6]  
BUTLER J, 1987, British Journal of Cancer, V55, P53
[7]   Mitochondrial free radical generation, oxidative stress, and aging [J].
Cadenas, E ;
Davies, KJA .
FREE RADICAL BIOLOGY AND MEDICINE, 2000, 29 (3-4) :222-230
[8]   DNA DAMAGE AND CYTOTOXICITY OF MITOXANTRONE AND DOXORUBICIN IN DOXORUBICIN-SENSITIVE AND DOXORUBICIN-RESISTANT HUMAN COLON-CARCINOMA CELLS [J].
CAPOLONGO, L ;
BELVEDERE, G ;
DINCALCI, M .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (06) :430-434
[9]   Effects of doxorubicin, 4'-epirubicin, and antioxidant enzymes on the contractility of isolated cardiomyocytes [J].
Chan, EM ;
Thomas, MJ ;
Bandy, B ;
Tibbits, GF .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1996, 74 (08) :904-910
[10]   FORMATION OF ADRIAMYCIN - DNA-ADDUCTS IN-VITRO [J].
CULLINANE, C ;
CUTTS, SM ;
VANROSMALEN, A ;
PHILLIPS, DR .
NUCLEIC ACIDS RESEARCH, 1994, 22 (12) :2296-2303